Reinsurance Group is expanding underwriting opportunities, investment income and technology partnerships while balancing growth with disciplined capital returns.
Ford's F-Series production is rebounding, but weak U.S. sales, plunging EV demand and rising costs keep the stock outlook balanced.
Teva's TEV '408 meets its phase IIa celiac disease goal, preventing gluten-induced intestinal damage and showing a favorable safety profile.
VZ's cost cuts, customer-focused strategy and AI infrastructure push are fueling gains, but competition and high debt remain key concerns.
Ultragenyx plunges 46% after its phase III Angelman syndrome study fails to achieve key efficacy goals, putting apazunersen's future in question.
Mativ Holdings is transitioning from a leveraged paper asset aggregation to a qualification-driven specialty materials platform with widening EBITDA margins. Q2 2026 saw organic sales up 1.7% but adjusted EBITDA up 12%, driven by pricing, SG&A reductions, and product mix optimization. MATV's valuation is discounted versus peers despite double-digit EBITDA growth, rapid deleveraging, and strong free cash flow generation.
SK hynix leads the high-bandwidth memory (HBM) market, holding a 50% share, but Samsung is rapidly gaining ground. I see SK hynix and Samsung dominating future memory markets due to their leadership in HBM, HBF, and emerging HBS technologies. Micron risks marginalization by not investing in HBF, as I believe HBM + HBF will replace current AI memory architectures.
Sustained extreme fund flows in Bitcoin may signal impending market volatility, impacting investor sentiment and potential regulatory scrutiny. Bitcoin experiences extreme fund flows for six consecutive days, a pattern that historically precedes price drops.
A risk-on tape is lifting high-beta fuel cell names on Thursday, but the group is splitting sharply on the way up. Bloom Energy (NYSE:BE) stock is up 8% to $233.69 in midday trading.
Principal Financial's Beam Benefits acquisition expands its SMB reach, adding digital capabilities and supporting stronger Specialty Benefits growth.
AVO's Q3 outlook faces pressure from lower avocado prices, sourcing costs and blueberry headwinds, though integration and demand offer support.
Applied Materials is benefiting from AI-driven semiconductor demand, with advanced packaging, DRAM and HBM fueling growth as fab investments accelerate globally.
The Range Global Coal Index ETF (COAL) climbed 23.4% in August, outpacing both broad market equities and energy sector peers. During the month, the State Street SPDR S&P 500 ETF Trust (SPY) climbed 2.7%, while the State Street Energy Select Sector SPDR ETF (XLE) gained 7.4% over the same period.
Bitcoin price extended its recovery above $80,000 on Sept. 3 after Federal Reserve Governor Christopher Waller cooled expectations for a September rate hike, while the charts showed strong momentum approaching a critical resistance zone.
Uber and Wayve launch supervised autonomous rides in London, starting a gradual U.K. rollout tied to demand, tech readiness and regulation.
BCS' U.S. consumer, U.K. lending, and Investment Banking expansions lift total income by 11% in H1'26, boosting its revenue growth outlook for 2026 & beyond.
PFE's pipeline is taking center stage as berobenatide and next-generation oncology drugs aim to drive growth from 2028 and beyond.
CPB's Q4 earnings and sales miss estimates as inflation squeezes margins, while Snacks' weakness offsets gains in Meals & Beverages.
TTD's fast-growing JBPs are emerging as a key growth lever as macro pressures weigh on near-term performance.
Bitcoin (BTC) reclaimed $81,000 on Thursday as reports suggest the Iran war could be over. Reportedly, Donald Trump's inner circle is advising the president to declare the war officially over, as pressure over midterm elections grows.
Expeditors International of Washington, Inc. (EXPD) Discusses Impact of AI Investment Boom on Freight Markets and Global Supply Chains Transcript
There isn't enough participation, and the market is in limbo.
Tyson Foods updated its fiscal 2026 outlook Thursday. Investors aren't too pleased.
Rein Therapeutics advances LTI-03 in IPF. RENEW enrollment tops 25%, with interim data expected in the fourth quarter of 2026.
MET's diversified portfolio, strong cash generation and global growth support premium gains, while investment income volatility remains a key risk.
AbbVie's Skyrizi, Rinvoq and neuroscience drugs drive growth, but Humira erosion, oncology and Aesthetics remain key headwinds.
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. FTNT, EAT, LECO & LRCX are some such stocks.
On multiple occasions this year, President Donald Trump has publicly shown his support for Dell Technologies NYSE: DELL, telling Americans to “go out and buy a Dell computer” as recently as July 6.
Uphold says its Earn on XRP feature is in final development, targeting a platform that currently holds around 1.62 billion XRP. Because XRPL lacks native staking, Uphold must use external mechanisms such as DeFi lending or wrapped-token infrastructure to generate potential yield.
Equity Bancshares NYSE: EQBK has agreed to merge with Lincoln Bancorp, the parent company of Lincoln Savings Bank, in a transaction valued at approximately $123 million that would expand Equity's footprint in Iowa.